Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:BDMD NASDAQ:MBOT NASDAQ:NTRB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.37-8.1%$1.70$0.76▼$2.86$97.51M1.3183,174 shs123,906 shsBDMDBaird Medical Investment$3.76-7.4%$4.94$1.05▼$12.50$26.73M-0.94294,215 shs85,944 shsMBOTMicrobot Medical$2.48-1.2%$2.55$0.82▼$3.38$91.31M1.131.78 million shs870,713 shsNTRBNutriband$8.21-3.1%$7.06$3.72▼$11.78$94.48M1.1588,961 shs119,026 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical+12.47%+14.67%+54.49%+196.01%+86.96%BDMDBaird Medical Investment+3.84%+10.93%-9.58%-26.45%+405,999,900.00%MBOTMicrobot Medical-3.46%-0.40%-10.68%+80.58%+135.68%NTRBNutriband-12.90%+7.62%+10.00%+69.40%+44.79%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical1.6994 of 5 stars0.05.00.04.20.01.70.6BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AMBOTMicrobot Medical2.1769 of 5 stars3.52.00.00.03.10.00.6NTRBNutriband3.2122 of 5 stars3.55.00.00.01.91.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/ABDMDBaird Medical Investment 0.00N/AN/AN/AMBOTMicrobot Medical 3.00Buy$9.00262.90% UpsideNTRBNutriband 3.00Buy$13.0058.34% UpsideCurrent Analyst Ratings BreakdownLatest BDMD, MBOT, NTRB, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/10/2025MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$9.00 ➝ $9.00(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M1.86N/AN/A$0.38 per share6.24BDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/A$0.17 per shareN/ANTRBNutriband$2.14M42.78N/AN/A$0.58 per share14.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)BDMDBaird Medical InvestmentN/AN/A0.00∞N/AN/AN/AN/AN/AMBOTMicrobot Medical-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)NTRBNutriband-$10.48M-$0.90N/AN/AN/A-415.93%-68.25%-60.40%9/2/2025 (Estimated)Latest BDMD, MBOT, NTRB, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/30/2025Q1 2026NTRBNutriband-$0.13-$0.12+$0.01-$0.12$0.71 million$0.67 million5/21/2025Q1 2025MBOTMicrobot Medical-$0.15-$0.08+$0.07-$0.08N/AN/A5/8/2025Q1 2025APYXApyx Medical-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million4/28/2025Q4 2025NTRBNutriband-$0.12-$0.18-$0.06-$0.51$0.71 million$0.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ABDMDBaird Medical InvestmentN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ANTRBNutribandN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical3.215.454.64BDMDBaird Medical InvestmentN/AN/AN/AMBOTMicrobot MedicalN/A16.1916.19NTRBNutriband0.013.713.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%BDMDBaird Medical Investment19.78%MBOTMicrobot Medical16.30%NTRBNutriband19.70%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%BDMDBaird Medical Investment78.90%MBOTMicrobot Medical4.74%NTRBNutriband54.09%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.79 million32.05 millionOptionableBDMDBaird Medical InvestmentN/A6.58 million1.39 millionN/AMBOTMicrobot Medical2036.38 million34.65 millionOptionableNTRBNutriband1011.15 million5.12 millionNot OptionableBDMD, MBOT, NTRB, and APYX HeadlinesRecent News About These CompaniesNutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval - MorningstarJuly 3, 2025 | morningstar.comMNutriband declares 25% preferred stock dividend for shareholdersJuly 3, 2025 | uk.investing.comNutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approvalJuly 2, 2025 | globenewswire.comNutriband added to the Russell Microcap index, Russell Microcap Growth index, Russell 3000E index and Russell 3000E growth indexJuly 2, 2025 | msn.comNutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® IndexJuly 1, 2025 | globenewswire.comNutriband (NASDAQ:NTRB) Stock Price Up 1.7% - Here's WhyJune 27, 2025 | marketbeat.comNutriband, Kindeva Complete Commercial Scale-up for Aversa FentanylJune 23, 2025 | contractpharma.comCNutriband (NTRB) Gets a Buy from Noble FinancialJune 21, 2025 | theglobeandmail.comNutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl PatchJune 19, 2025 | manilatimes.netMNutriband (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal TechnologyJune 11, 2025 | theglobeandmail.comNutriband Inc.: Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent TechnologyJune 9, 2025 | finanznachrichten.deNutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent TechnologyJune 9, 2025 | globenewswire.comNutriband (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder ValueJune 6, 2025 | theglobeandmail.comNutriband (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl DevelopmentJune 4, 2025 | theglobeandmail.comNutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity ConferenceJune 3, 2025 | finance.yahoo.comNutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA FentanylJune 2, 2025 | finance.yahoo.comNutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue EstimatesMay 30, 2025 | zacks.comIBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.May 27, 2025 | finance.yahoo.comNutriband (NASDAQ: NTRB) Charts Path to CommercializationMay 24, 2025 | theglobeandmail.comNutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal PatchMay 15, 2025 | theglobeandmail.comNutriband projects strong sales for abuse-deterrent patchesMay 1, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDMD, MBOT, NTRB, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$2.37 -0.21 (-8.14%) Closing price 04:00 PM EasternExtended Trading$2.42 +0.05 (+2.11%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Baird Medical Investment NASDAQ:BDMD$3.76 -0.30 (-7.39%) As of 04:00 PM EasternBaird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Microbot Medical NASDAQ:MBOT$2.48 -0.03 (-1.20%) Closing price 04:00 PM EasternExtended Trading$2.51 +0.03 (+1.17%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Nutriband NASDAQ:NTRB$8.21 -0.26 (-3.07%) Closing price 04:00 PM EasternExtended Trading$8.20 -0.02 (-0.18%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
